Thermal Decomposition Products Testing of Medical Pressure-Sensitive Adhesives: Analytical Methods,

Thermal decomposition products testing of medical pressure-sensitive adhesives (PSAs) is an essential part of the chemical characterization and biocompatibility evaluation required for skin-contact medical devices such as transdermal patches, wound dressings, and surgical tapes. By combining thermogravimetric analysis with evolved-gas techniques such as TGA-FTIR, TGA-MS, pyrolysis-GC/MS, and headspace GC-MS, accredited third-party laboratories can identify and quantify volatile monomers, residual solvents, and degradation byproducts in accordance with ISO 10993, ASTM, and GB/T frameworks. This article outlines the sample types, analytical scope, testing methods, application scenarios, and frequently asked questions related to the detection of thermal decomposition products in medical PSAs.

Technical Overview

Medical pressure-sensitive adhesives (PSAs) are viscoelastic polymer systems that achieve instantaneous bonding to skin and device substrates under light applied pressure. They form the functional core of transdermal drug delivery patches, surgical and first-aid tapes, wound dressings, catheter and IV securement devices, ECG electrodes, wearable sensors, and scar-management sheets. The dominant chemistries are acrylic copolymers, silicone gels, and rubber/elastomer-resin blends, supplemented by hydrogel and polyurethane systems for specialty applications.

Throughout their life cycle, these adhesives encounter significant thermal stress: drying-oven and hot-melt coating operations during manufacture, moist-heat sterilization at 121 °C to 134 °C, radiation sterilization with its associated temperature rise, accelerated aging at 40 °C to 60 °C in shelf-life studies, and extreme transport or wear conditions. Elevated temperatures can trigger chain scission, depolymerization, thermo-oxidative reactions, hydrolysis, and cleavage of crosslinks or pendant groups, releasing residual monomers, process solvents, low-molecular-weight oligomers, aldehydes, ketones, carboxylic acids, cyclic siloxanes, and decomposition products of tackifier resins, antioxidants, and peroxide initiators.

Because these substances can migrate directly onto skin, wounds, or mucosal tissue, and may interact with incorporated active pharmaceutical ingredients, regulators expect documented chemical characterization and toxicological risk assessment. Thermal decomposition product testing supports ISO 10993-1 (biological evaluation within a risk management process), ISO 10993-13 (degradation products of polymeric medical devices), ISO 10993-18 (chemical characterization of materials), and ISO 10993-17 (toxicological risk assessment of leachables and degradation products), together with the corresponding GB/T 16886 series. The resulting data feed into biological evaluation files, extractables and leachables (E&L) reports, sterilization validation, and stability programs for regulatory submissions worldwide.

Testing Samples

Acrylic Medical Pressure-Sensitive Adhesives

Solvent-borne, waterborne, and hot-melt acrylic PSAs based on monomers such as 2-ethylhexyl acrylate, butyl acrylate, methyl acrylate, vinyl acetate, and acrylic acid. Typical analytical targets include unreacted monomers, initiator fragments, and thermo-oxidative carbonyl compounds released above the degradation onset.

Silicone Pressure-Sensitive Adhesives

Silicone gel and silicone resin-pressure-sensitive systems used for gentle skin contact and scar therapy. Thermal stress studies focus on cyclic dimethylsiloxanes (D3 to D10), linear siloxane oligomers, silanols, and catalyst residues from platinum- or tin-cured systems.

Rubber- and Elastomer-Based Adhesives

Natural rubber, styrene-isoprene-styrene (SIS), and styrene-butadiene-styrene (SBS) block copolymer adhesives formulated with rosin, terpene-phenolic, or C5/C9 hydrocarbon tackifiers. Decomposition screening targets styrene, isoprene, butadiene fragments, limonene, terpenes, phenolic species, abietic acid derivatives, and polycyclic aromatic hydrocarbons.

Hydrogel and Polyurethane Systems

Hydrocolloid and hydrogel adhesives containing hydrophilic polymers and humectants, as well as polyurethane-based systems, evaluated for amine catalyst residues, isocyanate-derived species, and dehydration byproducts.

Finished Medical Devices and Composite Constructions

Transdermal patches, wound dressings, surgical tapes, ECG and TENS electrodes, ostomy barriers, diagnostic biosensors, and their associated release liners, backing films, and absorbent pads, tested as intact laminates to capture interactions between adhesive, substrate, and drug.

Raw Materials and Formulation Components

Base polymer emulsions and melts, tackifier resins, crosslinkers, photoinitiators, thermal peroxide initiators, plasticizers, antioxidants, and fillers, tested individually for incoming quality control, supplier qualification, and formulation comparability studies.

Testing Items

Testing programs are tailored to the adhesive chemistry and the intended thermal exposure scenario, and typically cover the following categories:

• Thermal stability parameters: onset decomposition temperature, staged mass-loss profile, maximum degradation rate temperature, and residual char or inorganic fraction.
• Residual monomers: acrylic acid, butyl acrylate, 2-ethylhexyl acrylate, methyl acrylate, vinyl acetate, styrene, isoprene, and related polymerization residues.
• Residual process solvents: ethyl acetate, acetone, toluene, n-hexane, n-heptane, methanol, and isopropanol, evaluated against recognized residual solvent limit concepts.
• Volatile degradation products: formaldehyde, acetaldehyde, acrolein, acetone, methanol, formic and acetic acids, carbon monoxide, and carbon dioxide from thermo-oxidative pathways.
• Cyclic siloxanes D3 to D10 and linear oligomers for silicone-based systems.
• Tackifier and additive decomposition products: terpenes, phenol, cresols, abietate derivatives, quinone-type antioxidant oxidation products, benzoic acid, benzene, and cumene from peroxide initiators.
• Low-molecular-weight oligomer fragments amenable to chromatographic separation and identification.
• Inorganic decomposition residues and filler or catalyst elements quantified by ICP-OES or ICP-MS.
• Temperature-resolved release profiles distinguishing volatilization below 100 °C from true decomposition events at higher temperatures.
• Toxicological screening of the identified compound list against ISO 10993-17 tolerable exposure levels and established threshold of toxicological concern (TTC) values, with calculation of margins of safety.

Final reports present each detected species with its chemical name, CAS registry number, estimated concentration on a microgram-per-gram sample basis, the temperature window in which it evolves, and a risk-based evaluation relative to patient exposure.

Testing Methods

Thermogravimetric Analysis (TGA)

TGA is performed according to ISO 11358, ASTM E1131, and ASTM D3850, heating 5 to 20 mg samples from ambient temperature to 600–800 °C at controlled rates of 5 to 20 °C per minute under inert nitrogen and oxidative air atmospheres. The resulting mass-loss curves define the thermal stability envelope relative to sterilization and aging temperatures and stage the decomposition behavior for subsequent evolved-gas analysis.

Differential Scanning Calorimetry (DSC)

DSC per ISO 11357 and related ASTM methods measures glass transition, melting events, and oxidative induction behavior, for example following ASTM D3895 principles. These data help interpret whether observed mass loss reflects residual volatile release, softening, or genuine chemical degradation.

Evolved Gas Analysis: TGA-FTIR and TGA-MS

Coupling the thermobalance to a Fourier-transform infrared spectrometer or a mass spectrometer enables real-time, temperature-correlated identification of gases evolved during each mass-loss step. FTIR provides functional-group fingerprints such as carbonyls, hydrocarbons, and siloxanes, while MS delivers high-sensitivity tracking of diagnostic mass-to-charge signals, allowing researchers to pinpoint exactly when each decomposition product is generated.

Pyrolysis-GC/MS

Curie-point, resistive-filament, or microfurnace pyrolysis at 400 to 700 °C fragments the polymer matrix in a controlled manner, and the resulting products are separated by gas chromatography and identified by mass spectral library matching. This hyphenated technique is the workhorse for speciating individual monomers, oligomers, and additive fragments within complex adhesive formulations.

Static and Dynamic Headspace GC-MS

Equilibrium headspace and multiple-headspace extraction GC-MS quantify residual solvents and volatile organic compounds in adhesive films and finished devices, with incubation temperatures selected to simulate storage, transport, and sterilization conditions. Thermal desorption GC-MS extends sensitivity for larger or heterogeneous samples.

Complementary Chromatographic and Elemental Techniques

Thermally stressed extracts are further characterized by GC-MS and LC-MS/MS, including derivatization strategies such as DNPH derivatization for aldehyde quantification. ICP-OES and ICP-MS quantify inorganic residues, metal catalysts, and filler content in the decomposed matrix.

Study Design and Data Interpretation

Test protocols combine programmed heating scans with isothermal holds that reproduce moist-heat sterilization at 121 °C or 134 °C and accelerated aging conditions consistent with ASTM F1980. Unheated controls, method blanks, and replicate analyses allow differentiation of pre-existing volatiles from true thermal decomposition products, and the final compound lists are benchmarked against ISO 10993-17 exposure limits to support regulatory decision-making. Sample preparation generally follows the principles of ISO 10993-12.

Applications

Detection of thermal decomposition products in medical PSAs supports the full product life cycle, from formulation research to post-market investigation:

• Regulatory submissions, including chemical characterization packages supporting device registrations in major jurisdictions under frameworks such as the EU MDR and comparable national programs.
• ISO 10993 biological evaluation files and extractables and leachables (E&L) study reports for skin-contact and wound-contact devices.
• Sterilization compatibility validation for moist-heat, ethylene oxide, gamma, and electron-beam processes where heat contributes to material stress.
• Formulation development, including comparative screening of tackifiers, crosslinkers, and antioxidant packages for improved thermal robustness.
• Shelf-life and accelerated aging studies demonstrating that no new hazardous decomposition products appear over the claimed storage period.
• Failure and complaint investigations involving odor generation, discoloration, loss of tack, or unexplained skin irritation after heat exposure.
• Supplier qualification, incoming material control, and change management for adhesive raw materials and coated components.

FAQ

Why is thermal decomposition product testing required for medical pressure-sensitive adhesives?

Medical PSAs are repeatedly exposed to heat during coating, sterilization, aging, and use, and the resulting degradation products contact skin or wounds. Regulators therefore expect chemical characterization of degradation products under ISO 10993-18 and ISO 10993-13 and a toxicological risk assessment under ISO 10993-17 as part of overall biological evaluation.

What temperature conditions are simulated during testing?

Programmed TGA scans typically run from ambient temperature to 600–800 °C, while targeted isothermal studies reproduce moist-heat sterilization at 121 °C or 134 °C and accelerated aging at 40 °C to 60 °C. Both inert and oxidative atmospheres are evaluated because real-world degradation often involves oxygen.

Which techniques are used to identify the decomposition products?

A hyphenated analytical strategy is applied: TGA-FTIR and TGA-MS for real-time evolved-gas monitoring, pyrolysis-GC/MS for detailed compound speciation with mass spectral library matching, headspace GC-MS for volatiles and residual solvents, and LC-MS plus ICP techniques for non-volatile and inorganic species.

How are the results quantified and evaluated for safety?

Compounds are quantified using calibrated external standards where available or well-characterized relative response factors, and reported in micrograms per gram of sample. Each species is then compared with ISO 10993-17 tolerable exposure levels or recognized toxicological thresholds, and margins of safety are calculated for the intended patient-contact scenario.

How is thermal decomposition distinguished from ordinary residual volatiles?

Temperature-resolved release profiles are the key: residual solvents and absorbed moisture typically evolve below approximately 100 °C, while true decomposition products appear at the characteristic mass-loss steps above the degradation onset. Unheated control samples and blank subtraction further confirm the origin of each detected species.

How much sample is required and how long does testing take?

TGA and headspace methods generally require only 5 to 100 milligrams per replicate, while full device laminate studies may use several grams to satisfy ISO 10993-12 sample preparation principles. A standard screening package is typically completed within two to four weeks, with complex non-targeted studies requiring additional time for confirmatory work.

Which standards govern this testing?

Core references include the ISO 10993 series, particularly parts 1, 12, 13, 17, and 18, the corresponding GB/T 16886 series, ISO 11357 and ISO 11358 for thermal analysis, and ASTM E1131 and ASTM D3850 for thermogravimetric methods, supplemented by ASTM F1980 for accelerated aging design where applicable.